Alex Kwan 關進晞 (@kwanalexc) 's Twitter Profile
Alex Kwan 關進晞

@kwanalexc

Associate Professor at @CornellBME. Studying the neurobiology of psychiatric #drugs including #ketamine and #psychedelics.

ID: 2174463928

linkhttp://alexkwanlab.org calendar_today09-11-2013 13:06:18

3,3K Tweet

5,5K Followers

2,2K Following

Alex Kwan 關進晞 (@kwanalexc) 's Twitter Profile Photo

Delighted to see the study out at Nature Communications 👇 nature.com/articles/s4146… As a lab, we are keen to develop new methods that can help decide which novel psychoactive compound may be therapeutic

Alex Kwan 關進晞 (@kwanalexc) 's Twitter Profile Photo

We wrote a short Nature News & Views piece to highlight the exciting work by tina kim and Olson Lab Institute for Psychedelics and Neurotherapeutics. Novel neuron-tagging techniques used to dissect the mechanism of psychedelics ⚡🧠🤯 nature.com/articles/d4158…

Joshua Siegel (@realjoshsiegel) 's Twitter Profile Photo

This extraordinary psychedelic precision functional mapping dataset is now fully/freely available to all! All the info to access & use it in a newly published Nature Scientific Data Resource: rdcu.be/epxe7 Thanks to the incredible team who created it - Subha S, Rick

Jason Sheltzer (@jsheltzer) 's Twitter Profile Photo

Many incredible biomedical scientists have left academia for biotech/pharma. While also noting many caveats, I want to share the observation that among top scientists who left academia for industry, their biggest new discoveries almost always happened in academia:

Many incredible biomedical scientists have left academia for biotech/pharma.

While also noting many caveats, I want to share the observation that among top scientists who left academia for industry, their biggest new discoveries almost always happened in academia:
Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle “Rest assured, we’ve got something pretty special here”, $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha. psychedelicalpha.com/news/compass-p…

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

“Rest assured, we’ve got something pretty special here”, $CMPS Chief Commercial Officer Englebert told Psychedelic Alpha.

psychedelicalpha.com/news/compass-p…